Stay updated on Safety of REL-1017 in Major Depressive Disorder Clinical Trial

Sign up to get notified when there's something new on the Safety of REL-1017 in Major Depressive Disorder Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of REL-1017 in Major Depressive Disorder Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the safety assessment of REL-1017 for Major Depressive Disorder in a Phase 3 clinical trial.
    Difference
    0.1%
    Check dated 2024-06-06T14:48:55.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The webpage has updated the 'Participation Criteria' section to provide detailed eligibility criteria for study participants, including age range and specific health conditions required for inclusion, as well as exclusion criteria for the study on Major Depressive Disorder.
    Difference
    9%
    Check dated 2024-05-22T21:28:42.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:31:10.000Z thumbnail image

Stay in the know with updates to Safety of REL-1017 in Major Depressive Disorder Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of REL-1017 in Major Depressive Disorder Clinical Trial page.